2015 Form 10-K Financial Statement

#000114420416083153 Filed on February 18, 2016

View on sec.gov

Income Statement

Concept 2015 2014 Q4 2014 Q3
Revenue $8.522M $911.00 $64.43K
YoY Change 1510.99% -99.99% 22.73%
Cost Of Revenue $9.103M $0.00 $305.8K
YoY Change 1726.22% -100.0% 1388.31%
Gross Profit -$580.6K -$806.00 -$241.4K
YoY Change -2000.06% -100.01% -855.61%
Gross Profit Margin -6.81% -88.47% -374.69%
Selling, General & Admin $9.118M $5.170M $1.834M
YoY Change 2.34% 695.38% 101.06%
% of Gross Profit
Research & Development $1.571M $380.0K $349.3K
YoY Change 29.17% 52.0% 144.44%
% of Gross Profit
Depreciation & Amortization $676.3K $150.0K $74.73K
YoY Change 46.14% -600.0% 24.55%
% of Gross Profit
Operating Expenses $11.46M $5.720M $2.583M
YoY Change -2.84% 557.47% 144.82%
Operating Profit -$12.04M -$5.717M -$2.825M
YoY Change 2.35% -196.74% 159.92%
Interest Expense $52.98K $130.0K $1.788K
YoY Change 646.86% -101.28% -100.01%
% of Operating Profit
Other Income/Expense, Net $1.012M $0.00 $100.5K
YoY Change -126.44% -100.0% -100.7%
Pretax Income -$11.03M -$5.590M -$2.720M
YoY Change -29.26% -28.52% -82.3%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$11.03M -$5.590M -$2.724M
YoY Change -29.26% -28.52% -82.28%
Net Earnings / Revenue -129.45% -613623.05% -4228.26%
Basic Earnings Per Share
Diluted Earnings Per Share -$161.9K -$87.47K -$45.26K
COMMON SHARES
Basic Shares Outstanding 68.14M shares 64.33M shares 60.10M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2015 2014 Q4 2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.760M $6.400M $10.02M
YoY Change -41.27% 9.78% 863.46%
Cash & Equivalents $6.403M $10.02M
Short-Term Investments
Other Short-Term Assets $710.1K $2.190M $4.220M
YoY Change -67.62% 376.09% 21000.0%
Inventory $2.706M $2.065M $1.750M
Prepaid Expenses $214.5K $175.0K
Receivables $51.23K $0.00 $40.00K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $7.228M $10.71M $16.04M
YoY Change -32.49% 38.26% 569.66%
LONG-TERM ASSETS
Property, Plant & Equipment $2.556M $2.851M $2.881M
YoY Change -10.34% -4.91% 10848.32%
Goodwill $852.0K
YoY Change
Intangibles $7.078M $5.528M
YoY Change 358.15% 289.55%
Long-Term Investments $1.223M $1.320M $1.390M
YoY Change -7.26% -82.47%
Other Assets $5.528M
YoY Change
Total Long-Term Assets $11.14M $11.25M $10.65M
YoY Change -0.93% 628.0% 637.11%
TOTAL ASSETS
Total Short-Term Assets $7.228M $10.71M $16.04M
Total Long-Term Assets $11.14M $11.25M $10.65M
Total Assets $18.37M $21.95M $26.69M
YoY Change -16.32% 78.68% 595.05%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.283M $884.4K $490.0K
YoY Change 45.11% 1517.88% -3.91%
Accrued Expenses $1.644M $1.082M $1.830M
YoY Change 27.11% 87.86% 1208.88%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $170.0K $170.0K
YoY Change -100.0% 0.0% 0.0%
Long-Term Debt Due $308.6K $320.0K
YoY Change -3.72%
Total Short-Term Liabilities $3.236M $2.673M $2.500M
YoY Change 21.05% 171.6% 13.3%
LONG-TERM LIABILITIES
Long-Term Debt $307.9K $610.0K $0.00
YoY Change -49.12%
Other Long-Term Liabilities $3.098M $3.460M $3.220M
YoY Change -8.47% -82.73%
Total Long-Term Liabilities $3.406M $4.070M $3.220M
YoY Change 462.75% 7.67% -82.73%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.236M $2.673M $2.500M
Total Long-Term Liabilities $3.406M $4.070M $3.220M
Total Liabilities $6.642M $6.734M $6.560M
YoY Change -1.36% 41.35% -68.53%
SHAREHOLDERS EQUITY
Retained Earnings -$55.53M -$49.93M
YoY Change 39.06% 55.52%
Common Stock $641.00 $641.00
YoY Change 12.65%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $11.73M $15.22M $20.13M
YoY Change
Total Liabilities & Shareholders Equity $18.37M $21.95M $26.69M
YoY Change -16.32% 78.68% 595.05%

Cashflow Statement

Concept 2015 2014 Q4 2014 Q3
OPERATING ACTIVITIES
Net Income -$11.03M -$5.590M -$2.724M
YoY Change -29.26% -28.52% -82.28%
Depreciation, Depletion And Amortization $676.3K $150.0K $74.73K
YoY Change 46.14% -600.0% 24.55%
Cash From Operating Activities -$7.322M -$2.780M -$1.570M
YoY Change 11.23% -144.27% 72.53%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$270.0K -$370.0K
YoY Change -60.29% 516.67%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$560.0K -$1.580M
YoY Change -100.0% -81.14% 15700.0%
Cash From Investing Activities -$450.7K -$830.0K -$1.950M
YoY Change -83.36% -77.26% 3150.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $5.130M 0.000 9.350M
YoY Change -47.99% -100.0% 499.36%
NET CHANGE
Cash From Operating Activities -$7.322M -2.780M -1.570M
Cash From Investing Activities -$450.7K -830.0K -1.950M
Cash From Financing Activities $5.130M 0.000 9.350M
Net Change In Cash -$2.642M -3.610M 5.830M
YoY Change -561.88% -175.21% 888.14%
FREE CASH FLOW
Cash From Operating Activities -$7.322M -$2.780M -$1.570M
Capital Expenditures $0.00 -$270.0K -$370.0K
Free Cash Flow -$7.322M -$2.510M -$1.200M
YoY Change 11.23% -136.06% 41.18%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
5130082 USD
CY2015 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
61230 USD
CY2014 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
0 USD
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2642390 USD
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
572088 USD
CY2015 xxii Increase Decrease In Accrued Severance
IncreaseDecreaseInAccruedSeverance
-225000 USD
CY2014 xxii Increase Decrease In Accrued Severance
IncreaseDecreaseInAccruedSeverance
0 USD
CY2013 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43635182 shares
CY2013 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4106694 USD
CY2013 us-gaap License Costs
LicenseCosts
413566 USD
CY2013 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
CY2015 xxii Amortization Of License Fees
AmortizationOfLicenseFees
98022 USD
CY2014 xxii Warrant Exchange Inducement Expense
WarrantExchangeInducementExpense
144548 USD
CY2015 xxii Warrant Exchange Inducement Expense
WarrantExchangeInducementExpense
0 USD
CY2014 xxii Amortization Of License Fees
AmortizationOfLicenseFees
32524 USD
CY2014 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
528991 USD
CY2014 us-gaap Cost Of Goods Sold
CostOfGoodsSold
252002 USD
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
8521998 USD
CY2015 us-gaap Cost Of Goods Sold
CostOfGoodsSold
9102560 USD
CY2015 us-gaap Gross Profit
GrossProfit
-580562 USD
CY2015 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1669387 USD
CY2014 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1249007 USD
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
1326393 USD
CY2015 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
2259147 USD
CY2014 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
620660 USD
CY2015 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
701534 USD
CY2014 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
214469 USD
CY2015 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
478955 USD
CY2014 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
625389 USD
CY2015 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
86332 USD
CY2014 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-93985 USD
CY2015 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
649271 USD
CY2013Q4 us-gaap Cash
Cash
5830599 USD
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
11728500 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
15219737 USD
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014 us-gaap Gross Profit
GrossProfit
30555 USD
CY2014 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
1176676 USD
CY2015 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
0 USD
CY2015 us-gaap License Costs
LicenseCosts
0 USD
CY2014 us-gaap License Costs
LicenseCosts
246434 USD
CY2015 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-15130 USD
CY2014 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
71121 USD
CY2013 us-gaap Cost Of Goods Sold
CostOfGoodsSold
48105 USD
CY2013 us-gaap Gross Profit
GrossProfit
6816712 USD
CY2013 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
744230 USD
CY2013 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
0 USD
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
1812447 USD
CY2013 xxii Gain Loss From Warrant Liability
GainLossFromWarrantLiability
-23602711 USD
CY2013 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
0 USD
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-26153158 USD
CY2013 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.6
CY2014Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
13674409 shares
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
2293083 USD
CY2014 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
2231385 USD
CY2014 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-179014 USD
CY2015 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0 USD
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-6582730 USD
CY2015 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-7321811 USD
CY2014 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
726989 USD
CY2015 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
413180 USD
CY2014 us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
212487 USD
CY2015 us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
37481 USD
CY2014 us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
631484 USD
CY2015 us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
0 USD
CY2014 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-2707992 USD
CY2015 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-450661 USD
CY2014 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
486951 USD
CY2015 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
50688 USD
CY2014 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
48300 USD
CY2015 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
CY2014 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
7471 USD
CY2015 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 USD
CY2014 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
9862810 USD
CY2015 us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
34500 USD
CY2014 us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
0 USD
CY2015 xxii Inventory Reserve Adjustments
InventoryReserveAdjustments
-60000 USD
CY2014 xxii Inventory Reserve Adjustments
InventoryReserveAdjustments
0 USD
CY2015 us-gaap Accretion Expense
AccretionExpense
45121 USD
CY2015 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
0 USD
CY2014 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
700000 USD
CY2015 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
-46069 USD
CY2014 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
4000 USD
CY2014 us-gaap Accretion Expense
AccretionExpense
0 USD
CY2014 xxii Payments For License Fees
PaymentsForLicenseFees
1450000 USD
CY2014 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
250000 USD
CY2015 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
5576083 USD
CY2014 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
0 USD
CY2013 xxii Amortization Of License Fees
AmortizationOfLicenseFees
0 USD
CY2013 xxii Warrant Exchange Inducement Expense
WarrantExchangeInducementExpense
3736313 USD
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
980162 USD
CY2013 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
1381800 USD
CY2013 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
175754 USD
CY2013 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
179014 USD
CY2013 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
290336 USD
CY2013 us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
0 USD
CY2013 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5200 USD
CY2013 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-3893 USD
CY2012Q4 us-gaap Cash
Cash
188 USD
CY2013 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-10044 USD
CY2013 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-629101 USD
CY2013 xxii Increase Decrease In Accrued Severance
IncreaseDecreaseInAccruedSeverance
0 USD
CY2013 us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
0 USD
CY2013 xxii Inventory Reserve Adjustments
InventoryReserveAdjustments
0 USD
CY2013 us-gaap Accretion Expense
AccretionExpense
0 USD
CY2013 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
0 USD
CY2013 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
5100 USD
CY2013 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
0 USD
CY2015Q4 xxii Inventory Tobacco Leaf Gross
InventoryTobaccoLeafGross
1816857 USD
CY2014Q4 xxii Inventory Tobacco Leaf Gross
InventoryTobaccoLeafGross
1537521 USD
CY2015Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
110623 USD
CY2014Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
50623 USD
CY2015Q4 us-gaap Inventory Finished Goods And Work In Process
InventoryFinishedGoodsAndWorkInProcess
342707 USD
CY2014Q4 us-gaap Inventory Finished Goods And Work In Process
InventoryFinishedGoodsAndWorkInProcess
154568 USD
CY2015Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
657389 USD
CY2014Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
423330 USD
CY2015 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
454612 USD
CY2014 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
265284 USD
CY2015Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.25
CY2015Q2 xxii Common Stock And Warrants Issued To Purchase Common Stock
CommonStockAndWarrantsIssuedToPurchaseCommonStock
3000000 shares
CY2015Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
1.00
CY2015Q4 xxii Fair Value Of Warrants
FairValueOfWarrants
2067000 USD
CY2015 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
105000 USD
CY2015 xxii Percentage Of Net Loss
PercentageOfNetLoss
0.25 pure
CY2014 xxii Finite Lived Intangible Assets Acquired With Notes Payable
FiniteLivedIntangibleAssetsAcquiredWithNotesPayable
925730 USD
CY2015Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
16634778 shares
CY2012Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
12972664 shares
CY2013Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
10653469 shares
CY2013Q4 xxii Class Of Warrant Or Right Issued
ClassOfWarrantOrRightIssued
11570274 shares
CY2013 xxii Class Of Warrants Or Rights Issued Under Warrant Exchange Program
ClassOfWarrantsOrRightsIssuedUnderWarrantExchangeProgram
138666 shares
CY2013 xxii Common Stock Warrants Issued Additional Number
CommonStockWarrantsIssuedAdditionalNumber
1665400 shares
CY2013 xxii Number Of Warrants Exercised
NumberOfWarrantsExercised
9831414 shares
CY2013 xxii Number Of Warrants Exercised Under Warrant Exchange Program
NumberOfWarrantsExercisedUnderWarrantExchangeProgram
5862121 shares
CY2014 xxii Warrants Issued In Conjunction With Consulting Agreement
WarrantsIssuedInConjunctionWithConsultingAgreement
4250000 shares
CY2014 xxii Number Of Warrants Exercised
NumberOfWarrantsExercised
1247443 shares
CY2014 xxii Common Stock Warrants Issued Additional Number
CommonStockWarrantsIssuedAdditionalNumber
18383 shares
CY2015 xxii Warrants With Provision Of Anti Dilution
WarrantsWithProvisionOfAntiDilution
130178 shares
CY2015 xxii Warrants Without Provision Of Anti Dilution
WarrantsWithoutProvisionOfAntiDilution
16504600 shares
CY2015 xxii Warrants Issued In Conjunction With Registered Direct Offering
WarrantsIssuedInConjunctionWithRegisteredDirectOffering
3000000 shares
CY2015 us-gaap Research And Development Arrangement Contract To Perform For Others Costs Incurred Gross
ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross
379800 USD
CY2015Q4 us-gaap Research And Development Arrangement Contract To Perform For Others Costs Incurred Gross
ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross
116400 USD
CY2015 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2015 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
68143284 shares
CY2014 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
59993413 shares
CY2015Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
627000 USD
CY2015 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 34.1pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 27.5pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <strong><i>Reclassifications</i></strong> <i>-</i> Certain items in the 2014 and 2013 financial statements have been reclassified to conform to the 2015 classification.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2013 us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.0189 pure
CY2013 us-gaap Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
0 pure
CY2013 us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
0.9 pure
CY2013 us-gaap Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
P10Y
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
465000 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
215000 shares
CY2013 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
20000 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
300000 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
890000 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
660000 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3161642 shares
CY2014 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
70000 shares
CY2015 xxii Share Based Compensation Arrangement By Sharebased Payment Award Options Reinstated In Period
ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsReinstatedInPeriod
50000 shares
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
2221642 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
790000 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.69
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.8
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.61
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.26
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.69
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.74
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.1
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.38
CY2015 xxii Share Based Compensation Arrangements By Share Based Payment Award Options Reinstated In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsReinstatedInPeriodWeightedAverageExercisePrice
0.69
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.1
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y10M24D
CY2015Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
420900 USD
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
71006844 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
71006844 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
64085042 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
64085042 shares
CY2015 us-gaap Licenses Revenue
LicensesRevenue
0 USD
CY2014 us-gaap Licenses Revenue
LicensesRevenue
0 USD
CY2013 us-gaap Licenses Revenue
LicensesRevenue
7000000 USD
CY2015 us-gaap Revenues
Revenues
8521998 USD
CY2014 us-gaap Revenues
Revenues
528991 USD
CY2013 us-gaap Revenues
Revenues
7278383 USD
CY2015 us-gaap Cost Of Revenue
CostOfRevenue
9102560 USD
CY2014 us-gaap Cost Of Revenue
CostOfRevenue
498436 USD
CY2014 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3827994 USD
CY2013 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-27965605 USD
CY2015Q1 us-gaap Supplemental Unemployment Benefits Severance Benefits
SupplementalUnemploymentBenefitsSeveranceBenefits
225000 USD
CY2015Q4 us-gaap Supplemental Unemployment Benefits Severance Benefits
SupplementalUnemploymentBenefitsSeveranceBenefits
675000 USD
CY2015Q1 us-gaap Litigation Reserve
LitigationReserve
46069 USD
CY2013 us-gaap Cost Of Revenue
CostOfRevenue
461671 USD
CY2015 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
1000000 USD
CY2014 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0 USD
CY2013 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0 USD
CY2015 xxii Income Tax Refund
IncomeTaxRefund
0 USD
CY2013 xxii Income Tax Refund
IncomeTaxRefund
-122024 USD
CY2014 xxii Income Tax Refund
IncomeTaxRefund
0 USD
CY2015 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1011952 USD
CY2015 us-gaap Depreciation
Depreciation
319699 USD
CY2014 us-gaap Depreciation
Depreciation
230012 USD
CY2013 us-gaap Depreciation
Depreciation
3028 USD
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11031931 USD
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-15595358 USD
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-26153158 USD
CY2015 us-gaap Operating Expenses
OperatingExpenses
11463321 USD
CY2014 us-gaap Operating Expenses
OperatingExpenses
11797919 USD
CY2013 us-gaap Operating Expenses
OperatingExpenses
5004265 USD
CY2015 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0 USD
CY2014 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0 USD
CY2013 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
4232 USD
CY2015 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 USD
CY2014 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 USD
CY2013 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
134296 USD
CY2015 us-gaap Severance Costs1
SeveranceCosts1
0 USD
CY2014 us-gaap Severance Costs1
SeveranceCosts1
624320 USD
CY2013 us-gaap Severance Costs1
SeveranceCosts1
0 USD
CY2015 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2014 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2013 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2015 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0 USD
CY2014 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0 USD
CY2013 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0 USD
CY2014 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 USD
CY2013 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 USD
CY2015 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 USD
CY2015 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-3372964 USD
CY2014 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-3494787 USD
CY2013 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
829306 USD
CY2015 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-155352 USD
CY2014 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
160319 USD
CY2013 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
186414 USD
CY2015 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3528316 USD
CY2014 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3334468 USD
CY2013 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1015720 USD
CY2015 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-3528316 USD
CY2014 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-3334468 USD
CY2013 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
1015720 USD
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2013 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 USD
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
457696 USD
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 USD
CY2015 xxii Payments For License Fees
PaymentsForLicenseFees
0 USD
CY2013 xxii Payments For License Fees
PaymentsForLicenseFees
0 USD
CY2015 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
0 USD
CY2013 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
0 USD
CY2015 xxii Net Proceeds From Warrant Exchange Program
NetProceedsFromWarrantExchangeProgram
0 USD
CY2013 xxii Net Proceeds From Warrant Exchange Program
NetProceedsFromWarrantExchangeProgram
3239385 USD
CY2015 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 USD
CY2014 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 USD
CY2013 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
150000 USD
CY2015 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
-0.340 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
-0.340 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
-0.340 pure
CY2015 us-gaap Effective Income Tax Rate Reconciliation Tax Settlements Other
EffectiveIncomeTaxRateReconciliationTaxSettlementsOther
0.0 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Tax Settlements Other
EffectiveIncomeTaxRateReconciliationTaxSettlementsOther
0.006 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Tax Settlements Other
EffectiveIncomeTaxRateReconciliationTaxSettlementsOther
0.019 pure
CY2015 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.005 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.084 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.355 pure
CY2015 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.031 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.025 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0 pure
CY2015 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
333333 USD
CY2013 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1620299 USD
CY2015 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.009 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.011 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.005 pure
CY2015 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.323 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.214 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.039 pure
CY2015 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0 pure
CY2014 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0 pure
CY2013 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0 pure
CY2014 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0 USD
CY2015 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 USD
CY2014 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 USD
CY2013 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
339250 USD
CY2015Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
7745734 USD
CY2014Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
4775536 USD
CY2013Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
2616624 USD
CY2015Q4 us-gaap Deferred Tax Assets Derivative Instruments
DeferredTaxAssetsDerivativeInstruments
0 USD
CY2014Q4 us-gaap Deferred Tax Assets Derivative Instruments
DeferredTaxAssetsDerivativeInstruments
0 USD
CY2013Q4 us-gaap Deferred Tax Assets Derivative Instruments
DeferredTaxAssetsDerivativeInstruments
21725 USD
CY2015Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
38707 USD
CY2014Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
17713 USD
CY2013Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
19584 USD
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1599916 USD
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
809319 USD
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
131450 USD
CY2015Q4 xxii Deferred Tax Liabilities Start Up Expenditures
DeferredTaxLiabilitiesStartUpExpenditures
514680 USD
CY2014Q4 xxii Deferred Tax Liabilities Start Up Expenditures
DeferredTaxLiabilitiesStartUpExpenditures
388130 USD
CY2013Q4 xxii Deferred Tax Liabilities Start Up Expenditures
DeferredTaxLiabilitiesStartUpExpenditures
0 USD
CY2015Q4 us-gaap Deferred Tax Assets Equity Method Investments
DeferredTaxAssetsEquityMethodInvestments
68877 USD
CY2014Q4 us-gaap Deferred Tax Assets Equity Method Investments
DeferredTaxAssetsEquityMethodInvestments
35398 USD
CY2013Q4 us-gaap Deferred Tax Assets Equity Method Investments
DeferredTaxAssetsEquityMethodInvestments
0 USD
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Severance Payments
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsSeverancePayments
147070 USD
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Severance Payments
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsSeverancePayments
218450 USD
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Severance Payments
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsSeverancePayments
0 USD
CY2015Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
9272 USD
CY2014Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
6561 USD
CY2013Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1292 USD
CY2015Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
10127755 USD
CY2014Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
6251107 USD
CY2013Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
2790675 USD
CY2014 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
71121 USD
CY2013 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 USD
CY2015Q4 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Inventory Costs
DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts
0 USD
CY2014Q4 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Inventory Costs
DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts
0 USD
CY2013Q4 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Inventory Costs
DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts
52445 USD
CY2015Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
227186 USD
CY2014Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
80251 USD
CY2013Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
2956 USD
CY2015Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
767044 USD
CY2014Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
624010 USD
CY2013Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
523157 USD
CY2015 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-15130 USD
CY2015Q4 xxii Deferred Tax Liabilities Other Intangible Assets
DeferredTaxLiabilitiesOtherIntangibleAssets
80349 USD
CY2014Q4 xxii Deferred Tax Liabilities Other Intangible Assets
DeferredTaxLiabilitiesOtherIntangibleAssets
21986 USD
CY2013Q4 xxii Deferred Tax Liabilities Other Intangible Assets
DeferredTaxLiabilitiesOtherIntangibleAssets
0 USD
CY2015Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1074579 USD
CY2014Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
726247 USD
CY2013Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
578558 USD
CY2015Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
9053176 USD
CY2014Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
5524860 USD
CY2013Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2212117 USD
CY2015Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2014Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2013Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2015Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
22300000 USD
CY2015 us-gaap Interest Paid Net
InterestPaidNet
7600 USD
CY2014 us-gaap Interest Paid Net
InterestPaidNet
7094 USD
CY2013 us-gaap Interest Paid Net
InterestPaidNet
135247 USD
CY2015 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2014 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2013 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2015 xxii Reclassification Of Derivative Liability To Equity Due To Warrant Amendments
ReclassificationOfDerivativeLiabilityToEquityDueToWarrantAmendments
0 USD
CY2014 xxii Reclassification Of Derivative Liability To Equity Due To Warrant Amendments
ReclassificationOfDerivativeLiabilityToEquityDueToWarrantAmendments
7367915 USD
CY2013 xxii Reclassification Of Derivative Liability To Equity Due To Warrant Amendments
ReclassificationOfDerivativeLiabilityToEquityDueToWarrantAmendments
14433178 USD
CY2015 xxii Patent And Trademark Additions Included In Accounts Payable
PatentAndTrademarkAdditionsIncludedInAccountsPayable
310078 USD
CY2014 xxii Patent And Trademark Additions Included In Accounts Payable
PatentAndTrademarkAdditionsIncludedInAccountsPayable
193454 USD
CY2013 xxii Patent And Trademark Additions Included In Accounts Payable
PatentAndTrademarkAdditionsIncludedInAccountsPayable
42490 USD
CY2015 xxii Reclassification Of Machinery And Equipment Purchases To Inventory
ReclassificationOfMachineryAndEquipmentPurchasesToInventory
0 USD
CY2014 xxii Reclassification Of Machinery And Equipment Purchases To Inventory
ReclassificationOfMachineryAndEquipmentPurchasesToInventory
37856 USD
CY2013 xxii Reclassification Of Machinery And Equipment Purchases To Inventory
ReclassificationOfMachineryAndEquipmentPurchasesToInventory
0 USD
CY2015 xxii License Fee Included In Accrued Expenses
LicenseFeeIncludedInAccruedExpenses
0 USD
CY2014 xxii License Fee Included In Accrued Expenses
LicenseFeeIncludedInAccruedExpenses
300000 USD
CY2013 xxii License Fee Included In Accrued Expenses
LicenseFeeIncludedInAccruedExpenses
0 USD
CY2015 xxii Equity Investment Included In Accrued Expenses
EquityInvestmentIncludedInAccruedExpenses
0 USD
CY2014 xxii Equity Investment Included In Accrued Expenses
EquityInvestmentIncludedInAccruedExpenses
325000 USD
CY2013 xxii Equity Investment Included In Accrued Expenses
EquityInvestmentIncludedInAccruedExpenses
0 USD
CY2015 us-gaap Stock Issued1
StockIssued1
0 USD
CY2014 us-gaap Stock Issued1
StockIssued1
394500 USD
CY2013 us-gaap Stock Issued1
StockIssued1
0 USD
CY2015 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
0 USD
CY2014 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
1952000 USD
CY2013 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
0 USD
CY2015 xxii Issuance Of Derivative Liability Warrants Issued Under Consulting Agreement
IssuanceOfDerivativeLiabilityWarrantsIssuedUnderConsultingAgreement
0 USD
CY2014 xxii Issuance Of Derivative Liability Warrants Issued Under Consulting Agreement
IssuanceOfDerivativeLiabilityWarrantsIssuedUnderConsultingAgreement
2810000 USD
CY2013 xxii Issuance Of Derivative Liability Warrants Issued Under Consulting Agreement
IssuanceOfDerivativeLiabilityWarrantsIssuedUnderConsultingAgreement
0 USD
CY2015 xxii Warrants Issued Under Consulting Agreement Resulting In Capital
WarrantsIssuedUnderConsultingAgreementResultingInCapital
0 USD
CY2014 xxii Warrants Issued Under Consulting Agreement Resulting In Capital
WarrantsIssuedUnderConsultingAgreementResultingInCapital
1260000 USD
CY2013 xxii Warrants Issued Under Consulting Agreement Resulting In Capital
WarrantsIssuedUnderConsultingAgreementResultingInCapital
0 USD
CY2015 xxii Finite Lived Intangible Assets Acquired With Notes Payable
FiniteLivedIntangibleAssetsAcquiredWithNotesPayable
0 USD
CY2013 xxii Finite Lived Intangible Assets Acquired With Notes Payable
FiniteLivedIntangibleAssetsAcquiredWithNotesPayable
0 USD
CY2015 xxii Conversion Of Accounts Payable To Note Payable
ConversionOfAccountsPayableToNotePayable
0 USD
CY2014 xxii Conversion Of Accounts Payable To Note Payable
ConversionOfAccountsPayableToNotePayable
0 USD
CY2013 xxii Conversion Of Accounts Payable To Note Payable
ConversionOfAccountsPayableToNotePayable
769377 USD
CY2015 xxii Conversion Of Accrued Interest To Note Payable
ConversionOfAccruedInterestToNotePayable
0 USD
CY2014 xxii Conversion Of Accrued Interest To Note Payable
ConversionOfAccruedInterestToNotePayable
0 USD
CY2013 xxii Conversion Of Accrued Interest To Note Payable
ConversionOfAccruedInterestToNotePayable
26422 USD
CY2015 xxii Conversion Of Notes Payable And Accrued Interest To Common Stock
ConversionOfNotesPayableAndAccruedInterestToCommonStock
0 USD
CY2014 xxii Conversion Of Notes Payable And Accrued Interest To Common Stock
ConversionOfNotesPayableAndAccruedInterestToCommonStock
0 USD
CY2013 xxii Conversion Of Notes Payable And Accrued Interest To Common Stock
ConversionOfNotesPayableAndAccruedInterestToCommonStock
1650305 USD
CY2015 xxii Dividend Payable On Preferred Stock
DividendPayableOnPreferredStock
0 USD
CY2014 xxii Dividend Payable On Preferred Stock
DividendPayableOnPreferredStock
0 USD
CY2013 xxii Dividend Payable On Preferred Stock
DividendPayableOnPreferredStock
93361 USD
CY2015 xxii Issuance Of Common Stock Value In Payment Of Financing Cost
IssuanceOfCommonStockValueInPaymentOfFinancingCost
0 USD
CY2014 xxii Issuance Of Common Stock Value In Payment Of Financing Cost
IssuanceOfCommonStockValueInPaymentOfFinancingCost
0 USD
CY2013 xxii Issuance Of Common Stock Value In Payment Of Financing Cost
IssuanceOfCommonStockValueInPaymentOfFinancingCost
416666 USD
CY2015 xxii Refinance Of Note Payable To Accounts Payable
RefinanceOfNotePayableToAccountsPayable
0 USD
CY2014 xxii Refinance Of Note Payable To Accounts Payable
RefinanceOfNotePayableToAccountsPayable
0 USD
CY2013 xxii Refinance Of Note Payable To Accounts Payable
RefinanceOfNotePayableToAccountsPayable
57500 USD
CY2015 xxii Issuance Of Warrants As Derivative Liability Instrument
IssuanceOfWarrantsAsDerivativeLiabilityInstrument
0 USD
CY2014 xxii Issuance Of Warrants As Derivative Liability Instrument
IssuanceOfWarrantsAsDerivativeLiabilityInstrument
0 USD
CY2013 xxii Issuance Of Warrants As Derivative Liability Instrument
IssuanceOfWarrantsAsDerivativeLiabilityInstrument
5675634 USD
CY2015 xxii Increase Warrant Liability Adjustments
IncreaseWarrantLiabilityAdjustments
0 USD
CY2014 xxii Increase Warrant Liability Adjustments
IncreaseWarrantLiabilityAdjustments
0 USD
CY2013 xxii Increase Warrant Liability Adjustments
IncreaseWarrantLiabilityAdjustments
626328 USD
CY2015 xxii Reclassification Of Derivative Liability To Equity Due To Warrant Exchange Program
ReclassificationOfDerivativeLiabilityToEquityDueToWarrantExchangeProgram
0 USD
CY2014 xxii Reclassification Of Derivative Liability To Equity Due To Warrant Exchange Program
ReclassificationOfDerivativeLiabilityToEquityDueToWarrantExchangeProgram
0 USD
CY2013 xxii Reclassification Of Derivative Liability To Equity Due To Warrant Exchange Program
ReclassificationOfDerivativeLiabilityToEquityDueToWarrantExchangeProgram
19639465 USD
CY2015 xxii Issuance Of Common Stock Value For Fees
IssuanceOfCommonStockValueForFees
0 USD
CY2014 xxii Issuance Of Common Stock Value For Fees
IssuanceOfCommonStockValueForFees
0 USD
CY2013 xxii Issuance Of Common Stock Value For Fees
IssuanceOfCommonStockValueForFees
462000 USD
CY2015 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
325000 USD
CY2014 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
0 USD
CY2013 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
0 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
-6131217 USD
CY2013 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
0 USD
CY2013 xxii Stock Issues During Period Value Private Placement
StockIssuesDuringPeriodValuePrivatePlacement
0 USD
CY2013 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
0 USD
CY2013 xxii Stock Issued During Period Warrants Excercised Value
StockIssuedDuringPeriodWarrantsExcercisedValue
14097594 USD
CY2014 xxii Stock Issued During Period Warrants Excercised Value
StockIssuedDuringPeriodWarrantsExcercisedValue
486951 USD
CY2015 xxii Stock Issued During Period Warrants Excercised Value
StockIssuedDuringPeriodWarrantsExcercisedValue
50688 USD
CY2013 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5200 USD
CY2014 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
48300 USD
CY2013 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2361962 USD
CY2014 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2433253 USD
CY2015 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1623423 USD
CY2013 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
1660 USD
CY2013 xxii Stock Issued During Period Value Warrant Exchange Program
StockIssuedDuringPeriodValueWarrantExchangeProgram
23340847 USD
CY2013 us-gaap Dividends Common Stock Stock
DividendsCommonStockStock
0 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
7522888 USD
CY2014 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1260000 USD
CY2014 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
394500 USD
CY2014 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
25200 USD
CY2014 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
7367915 USD
CY2015 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
325000 USD
CY2015 us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
34500 USD
CY2014 xxii Common Stock Issues During Period Value Private Placement
CommonStockIssuesDuringPeriodValuePrivatePlacement
9324088 USD
CY2015 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 27.5pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 27.5pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <strong><i>Concentration of Credit Risk</i> -</strong> Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in financial institutions. Although the cash accounts exceed the federally insured deposit amount, management does not anticipate nonperformance by the financial institutions. Management reviews the financial viability of these institutions on a periodic basis.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2015 us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 27.5pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 27.5pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="left"><strong><i>Use of Estimates -</i></strong> The preparation of financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2015Q4 xxii Inventorytobacco Leaf Net
InventorytobaccoLeafNet
2816953 USD
CY2014Q4 xxii Inventorytobacco Leaf Net
InventorytobaccoLeafNet
2115419 USD
CY2015 us-gaap Sales Revenue Net
SalesRevenueNet
242658 USD
CY2014 us-gaap Sales Revenue Net
SalesRevenueNet
447535 USD
CY2015 us-gaap Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
7000000 USD
CY2013Q4 us-gaap Payments For Royalties
PaymentsForRoyalties
7000000 USD
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
169000 USD
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
141000 USD
CY2015 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
303637 USD
CY2014 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
224519 USD
CY2013Q1 us-gaap Stock And Warrants Issued During Period Value Preferred Stock And Warrants
StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
2500000 USD
CY2015 us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
2034664 USD
CY2015 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
19796420 shares
CY2014 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14814409 shares
CY2013 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11813469 shares
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
146000 USD
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
156000 USD
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
169000 USD
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
169000 USD
CY2014 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
27485 USD
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2221642 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
300000 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
215000 shares
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3111607 USD
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3086730 USD
CY2015Q4 us-gaap Defined Benefit Plan Funded Percentage
DefinedBenefitPlanFundedPercentage
0.03 pure
CY2015 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
56208 USD
CY2013 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
34873 USD
CY2015Q4 xxii Warrants Outstanding
WarrantsOutstanding
16634778 shares
CY2015 xxii Number Of Warrants Exercised
NumberOfWarrantsExercised
40000 shares
CY2013Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
3220000 USD
CY2014Q1 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
210000 USD
CY2014 xxii Severance Term
SeveranceTerm
P36M
CY2012Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
4173140 USD
CY2013Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
711675 USD
CY2013Q3 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
1622069 USD
CY2013Q1 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
6022319 USD
xxii Reclassification Of Warrant Liability To Equity Upon Exercise Of Warrants
ReclassificationOfWarrantLiabilityToEquityUponExerciseOfWarrants
204513 USD
xxii Reclassification Of Warrant Liability To Equity Upon Exercise Of Warrants
ReclassificationOfWarrantLiabilityToEquityUponExerciseOfWarrants
6542904 USD
CY2013Q4 xxii Reclassification Of Warrant Liability To Equity Upon Exercise Of Warrants
ReclassificationOfWarrantLiabilityToEquityUponExerciseOfWarrants
7712170 USD
CY2013Q4 xxii Inducement Costs From Warrant Amendments
InducementCostsFromWarrantAmendments
3274313 USD
CY2013Q4 xxii Reclassification Of Warrant Liability To Equity Resulting From Warrant Exchange Program
ReclassificationOfWarrantLiabilityToEquityResultingFromWarrantExchangeProgram
19639465 USD
CY2013Q4 us-gaap Derivative Loss On Derivative
DerivativeLossOnDerivative
19271977 USD
CY2013Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
3779522 USD
CY2014Q1 xxii Reclassification Of Derivative Liability To Equity Due To Warrant Amendments
ReclassificationOfDerivativeLiabilityToEquityDueToWarrantAmendments
-7367915 USD
CY2014Q1 xxii Inducement Costs From Warrant Amendments
InducementCostsFromWarrantAmendments
144548 USD
CY2014 us-gaap Derivative Loss On Derivative
DerivativeLossOnDerivative
3676691 USD
CY2015 us-gaap Derivative Gain On Derivative
DerivativeGainOnDerivative
144550 USD
CY2013Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
19616308 shares
CY2013Q4 us-gaap Derivative Instruments Not Designated As Hedging Instruments Liability At Fair Value
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue
3921381 USD
CY2014 xxii Warrants With Provision Of Anti Dilution
WarrantsWithProvisionOfAntiDilution
129809 shares
CY2015 us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
356590 USD
CY2014 us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
232760 USD
CY2013 us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
141261 USD
CY2015Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
1453812 USD
CY2014 xxii Patent And Trademark Additions Included In Accrued Expenses
PatentAndTrademarkAdditionsIncludedInAccruedExpenses
0 USD
CY2013 xxii Patent And Trademark Additions Included In Accrued Expenses
PatentAndTrademarkAdditionsIncludedInAccruedExpenses
0 USD
CY2015 xxii Machinery And Equipment Additions Included In Accounts Payable
MachineryAndEquipmentAdditionsIncludedInAccountsPayable
2525 USD
CY2015 xxii Percentage Of Warrants Outstanding
PercentageOfWarrantsOutstanding
0.087 pure
CY2015 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
144500 USD
CY2014 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
3676691 USD
CY2013 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
19271977 USD
CY2015 xxii Milestone Payment
MilestonePayment
150000 USD
CY2015Q4 us-gaap Royalty Guarantees Commitments Amount
RoyaltyGuaranteesCommitmentsAmount
75000 USD
CY2015 xxii Non Cash Interest On Convertible Debt
NonCashInterestOnConvertibleDebt
0 USD
CY2014 xxii Non Cash Interest On Convertible Debt
NonCashInterestOnConvertibleDebt
0 USD
CY2013 xxii Non Cash Interest On Convertible Debt
NonCashInterestOnConvertibleDebt
526448 USD
CY2015 xxii Allowance For Doubtful Accounts Receivable Increase Decrease
AllowanceForDoubtfulAccountsReceivableIncreaseDecrease
-10000 USD
CY2014 xxii Allowance For Doubtful Accounts Receivable Increase Decrease
AllowanceForDoubtfulAccountsReceivableIncreaseDecrease
0 USD
CY2013 xxii Allowance For Doubtful Accounts Receivable Increase Decrease
AllowanceForDoubtfulAccountsReceivableIncreaseDecrease
0 USD
CY2015Q4 us-gaap Operating Leases Rent Expense Minimum Rentals
OperatingLeasesRentExpenseMinimumRentals
3750 USD
CY2015 us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
174925 USD
CY2014 us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
0 USD
CY2013 us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
0 USD
CY2015Q4 us-gaap Land Subject To Ground Leases
LandSubjectToGroundLeases
0 acre
CY2015Q4 us-gaap Lessee Leasing Arrangements Operating Leases Term Of Contract
LesseeLeasingArrangementsOperatingLeasesTermOfContract
P1Y
CY2015 xxii Patent And Trademark Additions Included In Accrued Expenses
PatentAndTrademarkAdditionsIncludedInAccruedExpenses
17715 USD
CY2014 xxii Machinery And Equipment Additions Included In Accounts Payable
MachineryAndEquipmentAdditionsIncludedInAccountsPayable
10904 USD
CY2013 xxii Machinery And Equipment Additions Included In Accounts Payable
MachineryAndEquipmentAdditionsIncludedInAccountsPayable
0 USD
CY2015 xxii Other Noncash Capital Contributions
OtherNoncashCapitalContributions
0 USD
CY2014 xxii Other Noncash Capital Contributions
OtherNoncashCapitalContributions
25200 USD
CY2013 xxii Other Noncash Capital Contributions
OtherNoncashCapitalContributions
0 USD
CY2015 xxii Amortization Of Patent Costs
AmortizationOfPatentCosts
356590 USD
CY2014 xxii Amortization Of Patent Costs
AmortizationOfPatentCosts
232760 USD
CY2013 xxii Amortization Of Patent Costs
AmortizationOfPatentCosts
141261 USD
CY2014 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
0 USD
CY2013 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
1660 USD
CY2015 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
0 USD
CY2015 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
5576083 USD
CY2015Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
10000 USD
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 USD
CY2013Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
179014 USD
CY2014 xxii Net Proceeds From Warrant Exchange Program
NetProceedsFromWarrantExchangeProgram
0 USD
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1317030 USD
CY2015Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
0 USD
CY2014Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
0 USD
CY2015Q2 xxii Warrants Expiration Period
WarrantsExpirationPeriod
P66M
us-gaap Proceeds From Legal Settlements
ProceedsFromLegalSettlements
500000 USD
us-gaap Proceeds From Legal Settlements
ProceedsFromLegalSettlements
500000 USD
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
206500 USD
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
103250 USD
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
242160 USD
CY2015 xxii Capitalized Patent Costs Gross
CapitalizedPatentCostsGross
178992 USD
CY2014 xxii Capitalized Patent Costs Gross
CapitalizedPatentCostsGross
123968 USD
CY2013 xxii Capitalized Patent Costs Gross
CapitalizedPatentCostsGross
101902 USD
CY2015 us-gaap Research And Development Arrangement Contract To Perform For Others Description And Terms
ResearchAndDevelopmentArrangementContractToPerformForOthersDescriptionAndTerms
12 months
CY2015 xxii Lease Payments
LeasePayments
126588 USD
CY2014 xxii Lease Payments
LeasePayments
97593 USD
CY2013 xxii Lease Payments
LeasePayments
0 USD
CY2013 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
4330734 USD
CY2013 xxii Reclassification Of Warrant Liability
ReclassificationOfWarrantLiability
343079 USD
CY2011Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
17386 USD
CY2012Q3 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
509062 USD
CY2014Q2 us-gaap Equity Method Investments
EquityMethodInvestments
250000 USD
CY2014Q1 xxii Research And Development Arrangement Contract Terms
ResearchAndDevelopmentArrangementContractTerms
two-year term
CY2015 dei Document Type
DocumentType
10-K
CY2015 dei Amendment Flag
AmendmentFlag
false
CY2015 dei Document Period End Date
DocumentPeriodEndDate
2015-12-31
CY2015 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
CY2015 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2015 dei Entity Registrant Name
EntityRegistrantName
22nd Century Group, Inc.
CY2015 dei Entity Central Index Key
EntityCentralIndexKey
0001347858
CY2015 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2015 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2015 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2015 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2015 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2015Q2 dei Entity Public Float
EntityPublicFloat
55200000 USD
CY2015 dei Trading Symbol
TradingSymbol
XXII
CY2016Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
76009960 shares
CY2013 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
141261 USD
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
3499 USD
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
0 USD
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
0 USD
CY2015 us-gaap Interest Expense
InterestExpense
52982 USD
CY2014 us-gaap Interest Expense
InterestExpense
7094 USD
CY2013 us-gaap Interest Expense
InterestExpense
748605 USD
CY2015 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
31198 USD
CY2014 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
30383 USD
CY2013 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
0 USD
CY2015Q1 us-gaap Revenues
Revenues
616138 USD
CY2015Q2 us-gaap Revenues
Revenues
2306953 USD
CY2015Q3 us-gaap Revenues
Revenues
2667506 USD
CY2015Q4 us-gaap Revenues
Revenues
2931401 USD
CY2015Q1 us-gaap Gross Profit
GrossProfit
-16442 USD
CY2015Q2 us-gaap Gross Profit
GrossProfit
-293493 USD
CY2015Q3 us-gaap Gross Profit
GrossProfit
-281422 USD
CY2015Q4 us-gaap Gross Profit
GrossProfit
10795 USD
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4119463 USD
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2346736 USD
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2747501 USD
CY2015Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-2830183 USD
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-4116739 USD
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-1288703 USD
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
-2761691 USD
CY2015Q4 us-gaap Net Income Loss
NetIncomeLoss
-2864798 USD
CY2015Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
CY2015Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2015Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
CY2015Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
CY2014Q1 us-gaap Revenues
Revenues
447535 USD
CY2014Q2 us-gaap Revenues
Revenues
16114 USD
CY2014Q3 us-gaap Revenues
Revenues
64431 USD
CY2014Q4 us-gaap Revenues
Revenues
911 USD
CY2014Q1 us-gaap Gross Profit
GrossProfit
269839 USD
CY2014Q2 us-gaap Gross Profit
GrossProfit
2938 USD
CY2014Q3 us-gaap Gross Profit
GrossProfit
-241416 USD
CY2014Q4 us-gaap Gross Profit
GrossProfit
-806 USD
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.07
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.68
CY2015Q4 us-gaap License Costs
LicenseCosts
150000 USD
CY2015Q4 us-gaap Royalty Guarantees Commitments Amount
RoyaltyGuaranteesCommitmentsAmount
10000 USD
CY2015Q4 xxii Minimum Annual Royalties In Year Four
MinimumAnnualRoyaltiesInYearFour
15000 USD
CY2014Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
CY2014Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.05
CY2014Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.09
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.58
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1187182 USD
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2038163 USD
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2824822 USD
CY2014Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-5717197 USD
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-5315128 USD
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-1965815 USD
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
-2724309 USD
CY2014Q4 us-gaap Net Income Loss
NetIncomeLoss
-5590106 USD
CY2014Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.09
CY2015Q4 xxii Minimum Annual Royalties In Year Five
MinimumAnnualRoyaltiesInYearFive
25000 USD
CY2015Q4 xxii Minimum Annual Royalties After Year Five
MinimumAnnualRoyaltiesAfterYearFive
50000 USD
CY2014Q1 us-gaap License Costs
LicenseCosts
85000 USD
CY2015 us-gaap Advertising Expense
AdvertisingExpense
229000 USD
CY2014 us-gaap Advertising Expense
AdvertisingExpense
30000 USD
CY2013 us-gaap Advertising Expense
AdvertisingExpense
9000 USD
CY2015 us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
5703000 USD

Files In Submission

Name View Source Status
0001144204-16-083153-index-headers.html Edgar Link pending
0001144204-16-083153-index.html Edgar Link pending
0001144204-16-083153.txt Edgar Link pending
0001144204-16-083153-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
image_002.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v430187_10k.htm Edgar Link pending
v430187_ex21-1.htm Edgar Link pending
v430187_ex23-1.htm Edgar Link pending
v430187_ex31-1.htm Edgar Link pending
v430187_ex31-2.htm Edgar Link pending
v430187_ex32-1.htm Edgar Link pending
xxii-20151231.xml Edgar Link completed
xxii-20151231.xsd Edgar Link pending
xxii-20151231_cal.xml Edgar Link unprocessable
xxii-20151231_def.xml Edgar Link unprocessable
xxii-20151231_lab.xml Edgar Link unprocessable
xxii-20151231_pre.xml Edgar Link unprocessable